ESMO Gastrointestinal Oncology Gastroenterology
The EvIDHence study: real-world treatment patterns and safety outcomes in mutant and wild-type IDH1 cholangiocarcinoma before availability of mIDH1 inhibitors
The publisher did not provide an abstract — full text is available via the link below.